AKT3 may be the primary target for mTORC2 activity, as ablation of the mTOR2 complex proteins Rictor and Sin1 was shown in mice to decrease AKT Ser473 activation, causing microcephaly and alterations in neuronal morphology and function [22]. The gene discussed is MAPKAP1; the disease is microcephaly.